Raama Finance Limited has scheduled a Board meeting on September 22, 2026 to consider the terms, conditions and allotment of unlisted, unsecured, redeemable non-convertible debentures worth up to ₹5 crore through private placement. The proposed issue forms part of the company's previously approved ₹100 crore NCD fundraising programme authorized by shareholders in August 2026.
Raama Finance to Consider ₹5 Crore NCD Issue at September 22 Board Meeting
Board to consider NCD allotment of up to ₹5 crore.
Issue forms part of the previously approved ₹100 crore fundraising programme.
Reader Takeaway: Debt fundraising process advances; final issue terms and allotment remain subject to Board approval.
What just happened
Raama Finance Limited has informed the exchanges that its Board of Directors will meet on September 22, 2026.
The principal agenda is to consider the terms, conditions and allotment of unlisted, unsecured, redeemable, non-convertible debentures (NCDs) through a private placement.
The proposed tranche has a face value of ₹10,000 per debenture and an aggregate issue size of up to ₹5 crore, or such other amount as may be approved by the Board.
Why this matters
The proposed issue represents the execution of an already approved debt fundraising plan rather than a fresh capital-raising proposal.
If approved, the NCD issuance will provide an additional source of funding without diluting existing shareholders' equity.
The backstory
The proposed issuance follows shareholder approval received through a postal ballot, the results of which were declared on August 11, 2026.
Under that approval, the company received authorization to raise up to ₹100 crore through the issuance of non-convertible debentures.
The current proposal relates to only one tranche of that broader fundraising programme.
What changes now
At the scheduled Board meeting, directors are expected to consider:
- Final terms and conditions of the proposed NCD issue.
- Allotment of NCDs up to ₹5 crore through private placement.
- Any related administrative matters.
The detailed commercial terms, including coupon, tenure and other issue conditions, are expected to be determined as part of the Board's deliberations.
Risks to watch
The filing announces only the Board meeting agenda and does not confirm completion of the issuance.
Investors should monitor subsequent disclosures for the final allotment, issue terms, interest rate, maturity profile and utilisation of the funds raised.